Commentary to a Paper by Flosadóttir & Bjarnason on Full Dapsone Dose Made Possible by Control of Anaemia with Darbepoetin-alpha.

The author reflects on the study which cited the effectiveness of dapsone-induced anaemia with darbepoetin-alpha. It discusses the findings of the study and asserts it chose erythropoietin, which was used successfully for 3 years. It implies that the dapsone dose could be increased, which controlled the symptoms and raised the haemoglobin. It assesses that it suggests a new concept in the management of dapsone-related anaemia and further studies are required to evaluate its place in therapy.